mucoviscidosis
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
12 Years to 17 Years
Inclusion criteria
Inclusion criteria: Patients with CF: - Ambulant patients with CF - free from acute pulmonary or gastro-intestinal exacerbation - from 12 to 18 years Healthy controls: - from 12 to 18 years - free from constraints in performing a maximal exercise test
Exclusion criteria
Exclusion criteria: Patients with CF: - Resting oxygen saturation (SpO2)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - * time of PCr recovery (31P MRS) - Resting, exercise and recovery phoscreatine (PCr)(31P MRS) - Resting, exercise and recovery Inorganic phosphorus (Pi)(31P MRS) - Resting, exercise and recovery Pi:PCr ratio(31P MRS) - Resting, exercise and recovery (Adenosine triphosphate) ATP(31P MRS) - Resting, exercise and recovery ATP:PCr ratio(31P MRS)Change in concentration deoxygenated hemoglobin. (NIRS) - Change in concentration oxygenated hemoglobin. (NIRS) - Change in concentration total hemoglobin. (NIRS) - Change in concentration deoxygenated hemoglobin minus change in concentration oxygenated hemoglobin. (NIRS) - The T1/2 (s) change in oxygenated hemoglobin in the recovery phase. (NIRS) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Peak workload (Wpeak) - Resting and peak oxygen uptake (VO2peak/kg (ml.min-1.kg-1) ) - Resting and peak minute ventilation (VEpeak) (l.min-1) - Resting and peak respiratory exchange ratio (RER = VCO2/VO2) - Resting and peak heart rate (HR; bpm) - Resting and peak SpO2 | — |
Countries
Netherlands
Outcome results
None listed